The federal Project Grant award of $1,793,411 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Rehabilitation Institute of Chicago (doing business as Shirley Ryan AbilityLab), a non-profit hospital and research institute. The funding will support a research project titled "SAFETY AND EFFICACY OF AMPAKINES FOR IMPROVEMENT OF BLADDER FUNCTION IN INDIVIDUALS WITH SCI" over the period of July 1, 2024 to June 30, 2027. The project aims to evaluate the safety and efficacy of ampakine compounds for improving bladder function in individuals with spinal cord injuries. As a leading provider of rehabilitation services and a prominent recipient of federal grants, the Rehabilitation Institute of Chicago has an extensive portfolio of research projects supported by agencies such as the National Institutes of Health and Department of Defense, focused on areas like prosthetics, neuroscience, and rehabilitation interventions.
Generated 1/28/25, 10:07 AM